Literature DB >> 3899551

The optimal application of forward and ninety-degree light scatter in flow cytometry for the gating of mononuclear cells.

J M Thompson, J R Gralow, R Levy, R A Miller.   

Abstract

Peripheral blood mononuclear cells from ten normal donors were labeled with a monoclonal antibody specific for monocytes and analyzed using a fluorescence activated cell sorter (FACS). Forward and 90 degrees light scatter parameters were studied in order to apply optimal computerized gating to identify and exclude monocytes from lymphocyte populations. An average of 9.45% versus 1.22% of cells, within chosen lymphocyte gates established by forward angle and 90 degrees scatter, respectively, were identified as monocytes. In samples from ten donors, the exclusion of monocytes from the lymphocyte population was more efficient using 90 degrees scatter than forward scatter. Simultaneous use of forward and 90 degrees scatter did not significantly improve the ability to accurately exclude monocytes, but did result in a significant increase in the improper exclusion of lymphocytes. Use of 90 degrees scatter alone, forward scatter alone, and forward and 90 degrees scatter simultaneously to identify lymphoid cells resulted in the exclusion of 12, 17, and 23% of lymphocytes from further analysis. The 90 degrees scatter alone appears to be the optimal method to eliminate monocytes electronically from mononuclear cell populations in which lymphocytes are being studied.

Mesh:

Substances:

Year:  1985        PMID: 3899551     DOI: 10.1002/cyto.990060503

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  9 in total

Review 1.  Diagnostic pathology and laboratory medicine in the age of "omics": a paper from the 2006 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  William G Finn
Journal:  J Mol Diagn       Date:  2007-07-25       Impact factor: 5.568

2.  Discrimination of myogenic and nonmyogenic cells from embryonic skeletal muscle by 90 degrees light scattering.

Authors:  Z Yablonka-Reuveni
Journal:  Cytometry       Date:  1988-03

3.  Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.

Authors:  I Corrales; A J Weersink; J Verhoef; K P van Kessel
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

4.  Purification and characterization of murine lipopolysaccharide-binding protein.

Authors:  P Gallay; S Carrel; M P Glauser; C Barras; R J Ulevitch; P S Tobias; J D Baumgartner; D Heumann
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

Review 5.  Current practices in laboratory monitoring of HIV infection.

Authors:  Madhu Vajpayee; Teena Mohan
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

6.  Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities.

Authors:  Magdalena Kovacsovics-Bankowski; Lana Chisholm; Jonna Vercellini; Christopher G Tucker; Ryan Montler; Daniel Haley; Philippa Newell; Jun Ma; Paul Tseng; Ronald Wolf; John T Vetto; Chet Hammill; Paul Hansen; Andrew D Weinberg
Journal:  J Immunother Cancer       Date:  2014-11-18       Impact factor: 13.751

7.  Decreased expression of T-cell costimulatory molecule CD28 on CD4 and CD8 T cells of mexican patients with pulmonary tuberculosis.

Authors:  German Bernal-Fernandez; Patricia Espinosa-Cueto; Rosario Leyva-Meza; Nathalie Mancilla; Raul Mancilla
Journal:  Tuberc Res Treat       Date:  2010-09-08

8.  Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.

Authors:  T van der Poll; M Levi; C E Hack; H ten Cate; S J van Deventer; A J Eerenberg; E R de Groot; J Jansen; H Gallati; H R Büller
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

9.  Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].

Authors:  S M Evans; B Joiner; W T Jenkins; K M Laughlin; E M Lord; C J Koch
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.